Endocrine pharmacotherapy · USMLE Step 1

A patient with type 1 diabetes begins insulin glargine. What is a major benefit of this formulation?

  1. Rapid onset
  2. Long, steady basal coverage
  3. Lower risk of hypoglycemia
  4. Ability to correct acute hyperkalemia
Show answer and explanation

Correct answer: Long, steady basal coverage

Insulin glargine provides extended, peakless basal insulin coverage for 24 hours.

Difficulty: Medium Question 13 of 20

Practice all 20 Endocrine pharmacotherapy questions

Keep practicing

More Endocrine pharmacotherapy questions